Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral ...

Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.

Over 11,000 bottles are being pulled from shelves after testing revealed a manufacturing error that introduced trace amounts ...

A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...

Bruker's Acquifer Imaging Machine (IM) is a fully automated widefield microscope with both brightfield and fluorescence ...

NeuroSense receives US FDA clearance to begin pivotal phase 3 trial for PrimeC in ALS: Cambridge, Massachusetts Wednesday, November 26, 2025, 13:00 Hrs [IST] NeuroSense Therapeuti ...

Glenmark Pharmaceuticals has recalled over eleven thousand bottles of its blood pressure drug Ziac after FDA testing found traces of the cholesterol medication ezetimibe. The Class III recall affects ...

Rezolute (RZLT) is poised for growth with key Phase 3 trial results ahead. Ersodetug targets both congenital and ...

If someone mentions criminal gangs, you might think of drug trafficking or financial crime. But one of the most persistent ...

Minoxidil is an established, first-line treatment for hair loss. There is less evidence to support the efficacy of hair loss ...

Doxycycline postexposure prophylaxis reduces chlamydia and syphilis in high-risk cohorts; however, unregulated access raises concerns about antimicrobial resistance.